Meticulous
Research®, leading global market research company published a research report
titled, “The Global Vaccines Market is
projected to $57.50 billion by 2025 growing at a CAGR of 7.9% during the
forecast period of 2018 to 2025.”
The Global Vaccines Market study presents historical market data in terms of values
(2016 and 2017), estimated current data (2018), and forecasts for 2025-Vaccines
Market By Indication (Pneumococcal, Influenza, DTP, HPV, Hepatitis,
Meningococcal, Rotavirus, Polio, MMR), Type (Live, Toxoid), Route Of
Administration (IM, SC, Oral), Valence (Monovalent, Multivalent) And Geography.
In 2017, the pneumococcal disease accounted
for the largest share of the global vaccines market. The large share of this
segment is mainly attributed to the high prevalence of pneumococcal disease in
pediatric, elderly, and immunocompromised populations. In addition, growing
number of pneumococcal diseases associated with chronic disease patients is
further driving the adoption of pneumococcal vaccines. However, meningococcal
disease vaccine segment is expected to grow at the highest CAGR in the next 5-7
years.
The growth of this market is mainly attributed
to high prevalence of diseases, increasing government initiatives towards
immunization, rising adoption of vaccines, technological advancement in vaccine
industry, and strong pipeline for vaccines.
The global vaccines market is highly
competitive with the presence of many players worldwide. With four big
pharmaceutical companies; GSK, Merck & Co., Inc., Pfizer, and Sanofi, the
vaccine industry is highly consolidated. CSL Limited, Emergent BioSolutions,
Johnson and Johnson, Serum Institute of India, Daiichi Sankyo, Takeda and
AstraZeneca are the other leading players of the global vaccines market. All these
players are focusing more on technologically-advanced vaccine products.
Read full Research Report Study On
North America accounted for the largest
share of the vaccines market with its well-established vaccination program. In
addition, factors such as the increasing prevalence of diseases, growing
adoption of advanced vaccines, and large pool of key players are further
expected to propel the growth of vaccines market in this region.The
intramuscular accounted for the largest share of the vaccines market. The large
share of this segment is mainly due to the availability of wide range of
vaccines for IM.
Key Topics Covered in This Report:
1.
Introduction
2.
Research
Methodology
3.
Executive
Summary
4.
Market
Share Analysis
5.
Market
Insights
6.
Global
Vaccines Market, by Indication
7.
Global
Vaccines Market, by Route of Administration
8.
Global
Vaccines Market, by Type/Antigen
9.
Global
Vaccines Market, by Valence
10. Vaccines Market, by Region
11. Competitive Landscape
12. Company Profiles
The Asia-Pacific vaccines market is
expected to grow at the highest CAGR of 8.9%. The growth in the APAC market is
mainly attributed to large patient pool, rising prevalence of diseases, growing
awareness on vaccination, increasing government initiatives, and expanding
presence of key players in this region. In addition, increasing disposable
income and growing awareness about heath in emerging countries are further
propelling the demand for vaccines in APAC region.
Hurry Up To Get Your Free Sample Report Now!
| Contact
– Khushal Bombe khushal@meticulousresearch.com Office No-402, 4th Floor, Pushpak Business Hub, Wakad, Pimpri-Chinchwad, 411057 India. Direct Lines: +1-646-781-8004 (North America) +91 744-7780008 (Asia-Pacific) |
No comments:
Post a Comment